Asian Pacific Association for Study of the Liver (APASL)
Overexpression of a DEAD box/RNA helicase protein, rck/p54, in human hepatocytes from patients with hepatitis C virus-related chronic hepatitis and its implication in hepatocellular carcinogenesis
Dual effects of hepatitis C virus Core protein on the transcription of cyclin-dependent kinase inhibitor p21 gene
YSDD: a novel mutation in HBV DNA polymerase confers clinical resistance to lamivudine
Liver p53 expression in patients with HCV-related chronic hepatitis
Twice-weekly administration of peginterferon-α-2b improves viral kinetics in patients with chronic hepatitis C genotype 1
Analysis of clinical, biochemical and viral factors associated with early relapse after lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B patients in Taiwan
Predicting progression to cirrhosis in chronic hepatitis C virus infection
Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection
Peginterferon α-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B
Interferon-α combined with ketoprofen as treatment of naïve patients with chronic hepatitis C: a randomized controlled trial
Modulation of endothelial cell inflammatory integrins and stress markers with rh-factor VIIa in patients with advanced chronic hepatitis C
Clinical relevance of total HCV Core antigen testing for hepatitis C monitoring and for predicting patients' response to therapy
Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; a marker distinct from viral DNA for monitoring lamivudine treatment
A rapid immunochromatographic assay for hepatitis B virus screening